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A 14-year-old girl had an asymptomatic lump on her scalp since
birth. Over the course of a few months, she noticed some asymp-
tomatic elevations, which slowly grew on the lesion (Figure 1A).
On physical examination, several erythematous papules, not tender
to the touch, were found on her right parietal scalp. There was a
large, soft plaque with an ill-deﬁned border underneath the pap-
ules, and some subcutaneous nodules were palpable in the plaque.
An incisional biopsy specimen of the scalp nodule revealed a
diffuse inﬁltrate extending into the subcutis (Figure 1B). In the up-
per dermis, many S-100 positive spindle cells exhibited neuroid
structures mixed together with adipocytes. These slender spindle
cells possessed wavy nuclei and showed a haphazard and fascicular
pattern in a ﬁbromyxoid matrix reminiscent of a neuroﬁbroma
(Figure 1C). Numerous nested pigmented melanocytes were
located in the deep dermis and perifollicular area (Figure 1D). The
elements in the upper dermis were stained with S-100 but were
negative for melan-A, indicating neural differentiation (Figure 2A
and B). The nested pigmented cells were highlighted with melan-
A stain (Figure 2C). Epithelial membrane antigen-positive slender
perineural cells were present in both the upper and middle dermis
(Figure 2D). The whole dermis and superﬁcial subcutis were inﬁl-
trated by these various neural and melanocytic components, thus
supporting a neurocristic hamartoma (NCH) diagnosis. A total exci-
sionwas suggested but the patient was reluctant to undergo imme-
diate extensive surgery. She has been followed for 1 year post
diagnosis without change.
NCH is a rare hamartomatous proliferation of melanocytic, neu-
roid, and mesenchymal tissues. The development of this condition
may be attributed to the aberrant development of neural crest cells,
especially in the cephalic regions.1 Clinically they are congenital or
acquired lesions presenting as pigmented macules, papules or nod-
ules with or without alopecia.1,2 Dermis or subcutaneous tissues are
frequently affected, and folliculocentric lesions may be observed.1
Most NCHs have a predilection for the scalp, but they have also
been reported to occur on the trunk and extremities.2,3
NCH shares many histological features with blue and congenital
nevi, and histopathological analysis is essential to differentiate it
from other dermal melanocytoses. Key NCH indicators include dis-
tribution of various cells, morphology and depth of dermal melano-
cytes, stromal components, and presence of neuroid
differentiation.4,5 It usually consists of a combination of dermal me-
lanocytes, spindle cells, pigmented dendritic cells, and SchwannianConﬂicts of interest: None declared.
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pseudorosettes, tactoid bodies, and prominent collections of mela-
nocytes around hair follicles, eccrine glands, nerves, and blood
vessels.1,3e5 Tumor growth may involve the subcutaneous fascia,
and deep inﬁltration into the skeletal muscle without overt malig-
nancy has also been described.3
Immunohistochemical stains are helpful in distinguishing NCH
fromother dermalmelanocytoses or nerve sheath tumors. Themel-
anocytic elements stain positive for S-100 protein, melan-A, and
HMB-45. The neuroid cell elements are positive for S-100 protein
but negative for melan-A and HMB-45, whereas the epithelial
membrane antigen stain may highlight perineural cells.1 Spindle
cells within the mucinous stroma commonly stain positive for
CD34, indicating proliferation of perifollicular ﬁbrous tissue.1,5
Congenital nevi with a neuroid component and plaque-type blue
nevus usually do not have stromal CD34 staining or perineural
cell markers.
NCH identiﬁcation is clinically important to avoid confusion
with other dermal melanocytoses and because of its malignancy
potential.4,6 Although its course is generally indolent, long-
standing NCH has been reported to give rise to cutaneous malig-
nant melanocytic neurocristic tumors.2,7,8 Therefore, it is important
to correctly differentiate NCH from other benign dermal melanocy-
toses, due to the possibility of malignant transformation. Malignant
NCH consists of a poorly circumscribed mass arising from the
dermis without in situ elements in the overlying epidermis, and pa-
thologists should be aware of this cytological atypia. In previous re-
ports, mitotic activity did not correlate with poor prognosis.2,8 It
seems that malignant NCH shows a less aggressive behavior than
melanoma, and patients may experience multiple recurrences
and hematogenous metastasis in the latter phase. Its malignant po-
tential is similar to a low-grade mesenchymal tumor.2 In a recent
study of three malignant NCH cases, no BRAF, NRAS, GNAQ, or KIT
mutations were found, suggesting that malignant NCH may be
distinct from conventional melanoma.8
The malignant tumors are mostly circumscribed, multinodu-
lar lesions which tend to recur as bulky nodules and metastasize
after years or decades. However, factors affecting the risk and
onset of malignant NCH transformation are still unknown.2,8
The time period for malignant tumor development has been esti-
mated to be 1e6 years for acquired NCH and 15e67 years for
congenital NCH.2 No guidelines are available for NCH manage-
ment because of the overall small number of cases. It has been
suggested that wide local excision should be considered to lessen
malignant potential. Patients should be given clear guidance
about possible risks and monitored with regular follow-up
examinations.2,4,8ier Taiwan LLC. All rights reserved.
Figure 1 (A) Clinically, after being shaved for the biopsy, there are many erythematous papules on a skin-colored, soft pebbly plaque on the right parietal scalp. (B) Tumor cells have
inﬁltrated the entire dermis with a folliculocentric distribution. (C) Higher magniﬁcation shows a neuroid structure mixed with adipose tissue in the upper dermis. (D) Grouped
pigmented melanocytes are present in the deep dermis and subcutis. (Hemotoxylin and eosin, original magniﬁcation B 20, C 200, and D 200).
Figure 2 Immunohistochemical stains. (A) The neuroid structures in the upper dermis are strongly positive for S-100 but negative for (B) melan-A. (C) The melanocytes are strongly
positive for melan-A. (D) The epithelial membrane antigen stain highlights the perineural cells in this hamartomatous proliferation. (Stain and original magniﬁcation: A, S-100
200; B, melan-A 200; C, melan-A 400; and D, epithelial membrane antigen 400).
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